YOU put a new guy in the chair...
First thing he does is
YOU put a new guy in the chair...
First thing he does is to transform the company in the MOST impactful way....
What are his motivations...WHO is he in league/aligned with ...shareholders or management..or BIG Pharma connections he's made in his past career.
HE/SHE wants to show effectiveness...WE owe a supplier 50 Million or so for product..NO revenue.
I am new ...so being the new CEO I will be deluged with OFFERS..mostly because of their market concerns/patents about to discontinue etc...etc.
They'll make it attractive to me personally because ultimately I'll pull the trigger. Likely stay on as a controlled unit. I'm thinking DILUTION to the MAX..in a quest to uplift to big board... looking for Institutional $$$$ to kickstart the whole shebang...I get Rich..and the shareholders get ..............F#(KED.....NEVER to realize the future value of the company.....Put your CAP back on... and think some more before you start blowing everybody out of the boardroom....consider the replacements.....BETTER the DEVIL you KNOW.
9
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Workhorse Group Faces Nasdaq Compliance Challenges Workhorse Group Inc (NASDAQ: WKHS), a manufacturer in the electric vehicle sector, has recently been issued a notice by the Nasdaq Stock Market regarding its non-compliance with the minimum bid price requirement. The pressing issue arises from the company's common stock trading below the $1.00 mark for a continuous period...
Continue Reading
Investors Have a Deadline to Join NET Power Class Action In a significant turn of events, Kahn Swick & Foti, LLC advises investors who’ve incurred losses exceeding $100,000 in NET Power Inc. to take action. If you are among those affected, the time is critical. You have until June 17, 2025 to file your lead plaintiff application in this securities class action lawsuit...
Continue Reading
Insight into Recent Share Purchases at Borregaard ASA Recently, significant transactions have emerged within Borregaard ASA that are noteworthy for investors and stakeholders alike. Tove Andersen, a dedicated member of the board, made headlines by acquiring 2,000 shares at a price of NOK 187.92 each. This purchase marks a decisive move, increasing her total holdings to...
Continue Reading
Guaranteed Roof Enhances Commercial Roofing Options in North Carolina Guaranteed Roof, recognized for its expertise in roof rejuvenation and replacement services, is excited to announce a major enhancement to its commercial division. This initiative strongly emphasizes the utilization of FAR Coatings, a cutting-edge solution for flat and low-slope roofs. By leveraging...
Continue Reading
Understanding the Class Action for Sage Therapeutics, Inc. As a diligent investor, knowing your rights is crucial, especially when involved with companies like Sage Therapeutics, Inc. (NASDAQ: SAGE). If you purchased securities between specific dates, it’s essential to pay attention to upcoming deadlines. The Importance of the Deadline The Rosen Law Firm, a leading...
Continue Reading